Wound treatment developer Advanced Medical Solutions grew profits by a third in the first half, with both branded and white label products selling well.
Group revenue climbed 11% to £27.4m, aided by currency effects, as increased margins helped pre-tax profit and diluted earnings both jump 33% to £6m and 2.49p per share respectively.
Chairman Don Evans said: "The first half of 2013 has seen another good performance by the group, with the benefits of our reorganisation already producing results, including another double-digit increase in revenues, further operating margin improvements and strong rises in profitability."
Net debt reduced to £2.6m and Evans added that strong net cash flow generation of £5.1m should continue and enable the AIM-listed company to have net funds by the year end.
"With further growth expected from our Branded Direct and OEM businesses, together with anticipated stronger progress in both Branded Distributed and Bulk Materials in the second half, we are confident of meeting current market expectations for the full year."
Operational highlights included further strong growth for Activheal, a cost-effective woundcare product designed for the NHS, and a return to growth for silver alginates, up 28% year on year.
Broker N1+ Singer noted that there was no new news on Liquiband in the US, with market share remaining flat at 4% in the key hospital segment.
A note from analysts Chris Glasper and Elizabeth Klein said growth was expected in the second half following the launch of a product variant and the signing up of new distributors.
They forecast £57.2m sales for the full year, adjusted pre-tax profits of £13.3m and adjusted earnings of 5.3p per share.
First-quarter results at Sports Direct were strong with sales up by nearly a fifth, as the sports retailer reiterated its full-year profit targets.
Group sales were up 18.2% in the 13 weeks to July 28th at £613.3m, up 18.2% from £519m the year before. Meanwhile, gross profit increased 23.2% from £211.1m to £260.1m.
Sports Direct said at the time of its full-year results in July that it was trading ahead of management's expectations in the first quarter, but warned that this could change given that this year is a "non-tournament year" and faces tough comparatives given the UEFA Championships and Olympics in 2012.
Sports Retail sales were up 14.5% at £505.3m, while the company saw impressive growth from its Premium Lifestyle unit with sales up 98.3% at £57.1m. The Brands division however saw more subdued growth of just 4.3% to £50.9m.
The company said that as it integrates its recent acquisitions - Republic in the UK, Sports Eybl & Sports Experts in Austria and Sportland in the Baltic region - it continues to target underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of £310m for the year to the end of April 2014 (this excludes the charge for the 2011 employee bonus share scheme). This compares with underlying EBITDA of £287.9m the year before.
"As we highlighted at our preliminary results in July, the group has experienced a strong start to the year with trading ahead of management's expectations," said Chief Executive Dave Forsey.
"This performance is in part attributable to the historic investment in gross margin; the on-going investment in product range and availability; and continued optimisation of our online and in-store product offer."